Hypertrophic and hypertensive hypertrophic cardiomyopathy--a true association?

Area of Science:

• Cardiology
• Pathophysiology
• Genetics

Background:

• Cardiomyopathies were historically defined as heart muscle diseases of unknown etiology.
• Increasing understanding has blurred the lines between idiopathic cardiomyopathies and specific heart muscle diseases.
• Specific cardiomyopathies are now recognized as heart diseases associated with specific cardiac or systemic disorders.

Purpose of the Study:

• To review hypertensive hypertrophic cardiomyopathy, a syndrome characterized by severe cardiac hypertrophy and distinct functional indices.
• To elucidate the pathophysiological, clinical, and diagnostic aspects of this specific cardiomyopathy.
• To explore potential correlations with genetic, inflammatory, and other markers.

Main Methods:

• Literature review focusing on pathophysiological, clinical, and diagnostic features.
• Analysis of existing data on hypertensive hypertrophic cardiomyopathy.
• Exploration of etiological and pathogenetic factors, including genetic and inflammatory markers.

Main Results:

• Hypertensive hypertrophic cardiomyopathy presents with severe concentric cardiac hypertrophy, a small left ventricular cavity, and supernormal systolic function.
• This syndrome occurs in the absence of concurrent medical illness or ischemic heart disease.
• The classification of cardiomyopathies is increasingly based on dominant pathophysiology or etiological factors.

Conclusions:

• The distinction between cardiomyopathy and specific heart muscle disease has evolved with advancing etiological understanding.
• Hypertensive hypertrophic cardiomyopathy represents a distinct clinical entity requiring comprehensive evaluation.
• Further research into genetic and inflammatory markers is crucial for a complete understanding of specific cardiomyopathies.